Literature DB >> 28302743

Heart Failure in Pediatric Patients With Congenital Heart Disease.

Robert B Hinton1, Stephanie M Ware2.   

Abstract

Heart failure (HF) is a complex clinical syndrome resulting from diverse primary and secondary causes and shared pathways of disease progression, correlating with substantial mortality, morbidity, and cost. HF in children is most commonly attributable to coexistent congenital heart disease, with different risks depending on the specific type of malformation. Current management and therapy for HF in children are extrapolated from treatment approaches in adults. This review discusses the causes, epidemiology, and manifestations of HF in children with congenital heart disease and presents the clinical, genetic, and molecular characteristics that are similar or distinct from adult HF. The objective of this review is to provide a framework for understanding rapidly increasing genetic and molecular information in the challenging context of detailed phenotyping. We review clinical and translational research studies of HF in congenital heart disease including at the genome, transcriptome, and epigenetic levels. Unresolved issues and directions for future study are presented.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular malformation; genetics; mutation; single ventricle; stem cell; ventricular dysfunction

Mesh:

Year:  2017        PMID: 28302743      PMCID: PMC5391045          DOI: 10.1161/CIRCRESAHA.116.308996

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  144 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

2.  DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.

Authors:  L A Jerome; V E Papaioannou
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice.

Authors:  E A Lindsay; F Vitelli; H Su; M Morishima; T Huynh; T Pramparo; V Jurecic; G Ogunrinu; H F Sutherland; P J Scambler; A Bradley; A Baldini
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Outcome of 121 patients with congenitally corrected transposition of the great arteries.

Authors:  J M Rutledge; M R Nihill; C D Fraser; O'Brian E Smith; C J McMahon; L I Bezold
Journal:  Pediatr Cardiol       Date:  2002-02-19       Impact factor: 1.655

Review 5.  Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart.

Authors:  John J Lehman; Daniel P Kelly
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

6.  Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study.

Authors:  T P Graham; Y D Bernard; B G Mellen; D Celermajer; H Baumgartner; F Cetta; H M Connolly; W R Davidson; M Dellborg; E Foster; W M Gersony; I H Gessner; R A Hurwitz; H Kaemmerer; J D Kugler; D J Murphy; J A Noonan; C Morris; J K Perloff; S P Sanders; J L Sutherland
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

7.  The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children.

Authors:  D Connolly; M Rutkowski; M Auslender; M Artman
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

8.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

9.  Elastin: mutational spectrum in supravalvular aortic stenosis.

Authors:  K Metcalfe; A K Rucka; L Smoot; G Hofstadler; G Tuzler; P McKeown; V Siu; A Rauch; J Dean; N Dennis; I Ellis; W Reardon; C Cytrynbaum; L Osborne; J R Yates; A P Read; D Donnai; M Tassabehji
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

Review 10.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

View more
  36 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

Review 2.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

3.  Correlation Between Cardiopulmonary Exercise Test, Spirometry, and Congenital Heart Disease Severity in Pediatric Population.

Authors:  Natalia Morales Mestre; Gregory Reychler; Christophe Goubau; Stéphane Moniotte
Journal:  Pediatr Cardiol       Date:  2019-03-08       Impact factor: 1.655

4.  A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle.

Authors:  Cai-Xia Lu; Wei Wang; Qian Wang; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

5.  Congenital Heart Disease: The Remarkable Journey From the "Post-Mortem Room" to Adult Clinics.

Authors:  Ali J Marian
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

6.  Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.

Authors:  Karan B Karki; Jeffrey A Towbin; Camden Harrell; James Tansey; Joseph Krebs; William Bigelow; Arun Saini; Sachin D Tadphale
Journal:  Pediatr Cardiol       Date:  2019-05-07       Impact factor: 1.655

7.  Risk Factors for Heart Failure and Its Costs Among Children with Complex Congenital Heart Disease in a Medicaid Cohort.

Authors:  Deipanjan Nandi; Joseph W Rossano; Yinding Wang; Jeanette M Jerrell
Journal:  Pediatr Cardiol       Date:  2017-08-29       Impact factor: 1.655

Review 8.  Wheezing in Infancy: An Overview of Recent Literature.

Authors:  Christine Muglia; John Oppenheimer
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-11       Impact factor: 4.806

9.  Chronic perinatal hypoxia delays cardiac maturation in a mouse model for cyanotic congenital heart disease.

Authors:  Jennifer Romanowicz; Devon Guerrelli; Zaenab Dhari; Colm Mulvany; Marissa Reilly; Luther Swift; Nimisha Vasandani; Manelle Ramadan; Linda Leatherbury; Nobuyuki Ishibashi; Nikki Gillum Posnack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-03-19       Impact factor: 4.733

10.  Utility of three-dimensional printing in preoperative planning for children with anomalous pulmonary venous connection: a single center experience.

Authors:  Jiajun Xu; Yangfan Tian; Jun Yin; Jinhua Wang; Weize Xu; Zhuo Shi; Jianzhong Fu; Qiang Shu
Journal:  Quant Imaging Med Surg       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.